The Quiet Revolution in Asthma Research
Asthma research in the United States has entered a period of remarkable momentum. Academic medical centers from Duke University to UCSF are running dozens of studies, and pharmaceutical companies are testing a new generation of treatments that target the immune pathways driving airway inflammation. The goal is no longer just symptom control. Researchers are chasing something bigger: treatments that could change the course of the disease itself.
One area drawing significant attention is biologic therapies. These are injectable medications that zero in on specific inflammatory molecules rather than blanketing the whole immune system. In late 2025, a new biologic called depemokimab received regulatory approval for severe asthma with an eosinophilic phenotype, based on trials conducted at 331 sites across 23 countries, with a quarter of participants enrolled in the United States. This once-every-six-months injection represents a shift toward less frequent dosing, which matters a great deal to people who juggle work, family, and the constant demands of managing a chronic condition.
The CHRONICLE study, sponsored by AstraZeneca, is tracking treatment patterns and health outcomes in people with severe asthma across the country. Meanwhile, the Severe Asthma Research Program continues its long-running effort to understand why some patients respond to therapy and others do not. These observational studies do not test new drugs, but they build the knowledge base that makes future breakthroughs possible.
What ties all of this together is a simple truth: asthma is not one disease. It is a collection of different biological processes that produce similar symptoms. The research community now understands this, and the clinical trials running today reflect that nuanced view.
Who Can Participate and What the Process Looks Like
Not everyone with asthma qualifies for a clinical trial, and that is by design. Each study has specific enrollment criteria that define exactly who the researchers need. Most trials require participants to be 18 years or older with a physician-confirmed asthma diagnosis and ongoing symptoms despite using controller medications. Some studies look for people with mild allergic asthma. Others seek out those with severe, treatment-resistant disease. A few focus specifically on children, particularly in urban settings where asthma rates and severity run disproportionately high.
The screening process typically begins with a phone call or online form. A research coordinator asks about your medical history, current medications, and symptom patterns. If you seem like a match, you come in for an in-person visit that may include lung function testing, allergy skin tests, blood work, and a physical exam. This screening visit is not a commitment to join the trial. It is a two-way evaluation: the team assesses whether you fit the study, and you decide whether the study fits your life.
Once enrolled, the experience varies by trial. Some studies last a few months with weekly visits. Others stretch over a year or more with appointments spaced further apart. You might receive an investigational medication, a placebo, or a treatment already on the market, depending on the study design. Many trials are randomized and double-blinded, meaning neither you nor the research team knows which group you are in until the study ends. This structure is what makes the data reliable.
One participant, a 42-year-old nurse from Texas named Maria, described her experience with a biologic trial as "surprisingly straightforward." She had been cycling through different inhalers for years without real relief. The trial required monthly visits to a clinic 40 minutes from her home, and she received a study drug injection each time. Within three months, her nighttime symptoms dropped sharply. She does not know for certain whether she received the active drug or the placebo, but the regular monitoring and access to a specialist she trusted made the whole process worthwhile regardless.
Types of Asthma Clinical Trials at a Glance
| Trial Type | What It Tests | Typical Duration | Who It Suits | Key Benefit | Potential Drawback |
|---|
| Phase II Biologic | New biologic drug safety and dosing | 6–12 months | Moderate to severe asthma | Access to cutting-edge treatment | Uncertain efficacy |
| Phase III Biologic | Confirmatory efficacy and safety | 12–24 months | Severe, uncontrolled asthma | Close specialist monitoring | Placebo possibility |
| Phase IV Post-Market | Real-world use of approved drugs | 6–18 months | Broad asthma populations | Drug already FDA-reviewed | May require frequent visits |
| Observational Registry | Treatment patterns and outcomes | 24+ months | Any severity level | No experimental drug | No direct treatment benefit |
| Inhaler/Device Study | New delivery methods or formulations | 3–12 months | Mild to moderate asthma | Simple, familiar intervention | Less novel than biologics |
| Pediatric/Urban Study | Asthma in children and specific populations | 12–36 months | Children, urban residents | Addresses health disparities | Parental involvement required |
What Participants Receive and What It Costs
A common misconception is that joining a clinical trial costs money. The opposite is true for asthma studies. Study-related medical evaluations, laboratory tests, and the investigational medication are provided at no cost to participants. The research sponsor covers these expenses. You do not need health insurance to participate, and you will not receive a bill for study-related procedures.
Beyond the medical care, most trials also provide financial compensation for time and travel. The amount depends on the study's length, the number of visits, and the procedures involved. Screening visits might offer modest compensation in the range of $50 to $125. Longer studies with multiple visits can provide more substantial amounts. For example, some asthma research centers have offered compensation reaching several thousand dollars for trials spanning many months. A study at Brigham and Women's Hospital in Boston listed compensation of up to $870 for an 18-month biologic trial, while another research site in Florida offered up to $2,100 for participation. The range is wide, and the study coordinator will explain the compensation structure before you consent to anything.
It is worth noting that compensation is not a salary. It is meant to offset the inconvenience of travel, parking, and the time you spend at the clinic. Some sites provide parking vouchers or reimburse transportation costs separately.
How to Find an Asthma Trial Near You
The most comprehensive starting point is ClinicalTrials.gov, a database maintained by the National Library of Medicine. You can search by condition, city, or zip code and filter results to show only studies that are actively recruiting. The interface takes a few minutes to learn, but the payoff is access to nearly every registered trial in the country. Use the "Recruiting and not yet recruiting" status filter, enter your location, and browse the results.
Academic medical centers are another excellent resource. Institutions like Duke, UCSF, the University of Virginia, and Brigham and Women's Hospital maintain their own asthma research pages with current studies listed. These sites often include direct contact information for the research team, which can shorten the path from inquiry to screening.
Private research clinics also run asthma trials. These facilities tend to be more accessible than major academic centers and may offer evening or weekend appointments. The trade-off is that they typically have fewer trials running at any given time.
When you find a study that interests you, reach out directly. The contact information is listed on every trial page. Expect a phone screening call first, followed by an in-person visit if you pass the initial eligibility check. Bring a list of your current medications and a summary of your asthma history to that first appointment. It speeds things up.
Making Sense of the Decision
The decision to join a clinical trial is personal. Some people participate because their current treatment is not working well enough. Others are motivated by the opportunity to contribute to medical knowledge that might help someone else down the road. Many are drawn by the combination of expert care and financial compensation.
A retired schoolteacher from Ohio named David joined an observational asthma registry after his pulmonologist mentioned it during a routine visit. "It was minimal effort on my part," he said. "I filled out some questionnaires every few months and let them look at my medical records. I liked knowing that my experience, even just the daily ups and downs of living with asthma, was adding to something bigger."
The research community needs participants from all backgrounds. Asthma affects people differently based on genetics, environment, occupation, and access to healthcare. Trials that enroll a diverse group of volunteers produce results that are more meaningful for everyone. This is especially important for communities that have been underrepresented in past research, including Black and Hispanic populations, who experience higher rates of asthma-related emergency department visits and hospitalizations.
If you are curious about what is available, start with a simple search on ClinicalTrials.gov or call the asthma research program at the nearest teaching hospital. There is no obligation. The screening visit is a conversation. You ask questions. They review your history. And if the fit is right, you take it from there.
研究の知恵